Ruconest (C1 esterase inhibitor [recombinant]) — United Healthcare
Hereditary angioedema (HAE)
Initial criteria
- Diagnosis of hereditary angioedema (HAE)
- Used for the treatment of acute HAE attacks
- Not used in combination with other products indicated for acute HAE attacks (e.g., Berinert, Firazyr, or Kalbitor)
Approval duration
12 months